Article Information
History
- July 11, 2018.
Article Versions
- You are currently viewing Version 1 of this article (July 11, 2018 - 08:24).
- Version 2 (August 28, 2018 - 17:27).
- View Version 3, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Guido España1,
- Yutong Yao1,
- Kathryn B. Anderson2,
- Meagan C. Fitzpatrick3,
- David L. Smith4,
- Amy C. Morrison5,6,
- Annelies Wilder-Smith7,8,9,
- Thomas W. Scott6 and
- T. Alex Perkins1
- 1Department of Biological Sciences and Eck Institute for Global Health, University of Notre Dame, IN 46556
- 2Department of Medicine, University of Minnesota Medical School, Minneapolis, MN 55455
- 3Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, MD 21201
- 4Institute for Health Metrics and Evaluation, University of Washington, Seattle, WA 98104
- 5United States Naval Medical Research Unit No. 6, Lima, Peru 34031
- 6Department of Entomology and Nematology, University of California, Davis, CA 95616
- 7Global Health and Vaccinology Programme, Lee Kong Chian School of Medicine, Singapore, 308232
- 8Department of Disease Control, London School of Hygiene and Tropical Medicine, London, UK
- 9Institute of Public Health, University of Heidelberg, Germany
- * Corresponding authors: guido.espana{at}nd.edu, taperkins{at}nd.edu
Posted July 11, 2018.
Model-based assessment of public health impact and cost-effectiveness of dengue vaccination following screening for prior exposure
